Merck Seeks Narrowed Arcoxia Indication In Response To “Approvable” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Company expects to hear from FDA in April on 30 mg and 60 mg once-daily doses of the Vioxx follow-on drug.